791 related articles for article (PubMed ID: 7503821)
21. A crossover, randomized, controlled trial of dornase alfa before versus after physiotherapy in cystic fibrosis.
Fitzgerald DA; Hilton J; Jepson B; Smith L
Pediatrics; 2005 Oct; 116(4):e549-54. PubMed ID: 16147970
[TBL] [Abstract][Full Text] [Related]
22. [New pharmacological approaches: rhDNase].
Tournier G; Sardet A; Grosskopf C; Baculard A; Delaisi B
Rev Pneumol Clin; 1995; 51(3):193-200. PubMed ID: 7569583
[TBL] [Abstract][Full Text] [Related]
23. Dornase alfa as postoperative therapy in cystic fibrosis sinonasal disease.
Cimmino M; Nardone M; Cavaliere M; Plantulli A; Sepe A; Esposito V; Mazzarella G; Raia V
Arch Otolaryngol Head Neck Surg; 2005 Dec; 131(12):1097-101. PubMed ID: 16365224
[TBL] [Abstract][Full Text] [Related]
24. Clinical trials of recombinant human DNase in cystic fibrosis patients.
Aitken ML
Monaldi Arch Chest Dis; 1993 Dec; 48(6):653-6. PubMed ID: 8124306
[TBL] [Abstract][Full Text] [Related]
25. Dornase alfa: a new option in the management of cystic fibrosis.
Witt DM; Anderson L
Pharmacotherapy; 1996; 16(1):40-8. PubMed ID: 8700791
[TBL] [Abstract][Full Text] [Related]
26. Effects of recombinant human DNase and hypertonic saline on airway inflammation in children with cystic fibrosis.
Suri R; Marshall LJ; Wallis C; Metcalfe C; Bush A; Shute JK
Am J Respir Crit Care Med; 2002 Aug; 166(3):352-5. PubMed ID: 12153969
[TBL] [Abstract][Full Text] [Related]
27. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group.
Ramsey BW; Pepe MS; Quan JM; Otto KL; Montgomery AB; Williams-Warren J; Vasiljev-K M; Borowitz D; Bowman CM; Marshall BC; Marshall S; Smith AL
N Engl J Med; 1999 Jan; 340(1):23-30. PubMed ID: 9878641
[TBL] [Abstract][Full Text] [Related]
28. In vivo effects of recombinant human DNase I on sputum in patients with cystic fibrosis.
Shah PL; Scott SF; Knight RA; Marriott C; Ranasinha C; Hodson ME
Thorax; 1996 Feb; 51(2):119-25. PubMed ID: 8711640
[TBL] [Abstract][Full Text] [Related]
29. Small airway deposition of dornase alfa during exacerbations in cystic fibrosis; a randomized controlled clinical trial.
Bakker EM; Volpi S; Salonini E; Müllinger B; Kroneberg P; Bakker M; Hop WC; Assael BM; Tiddens HA
Pediatr Pulmonol; 2014 Feb; 49(2):154-61. PubMed ID: 23913868
[TBL] [Abstract][Full Text] [Related]
30. Recombinant human DNase nebulisation in children with cystic fibrosis: before bedtime or after waking up?
van der Giessen LJ; Gosselink R; Hop WC; Tiddens HA
Eur Respir J; 2007 Oct; 30(4):763-8. PubMed ID: 17596273
[TBL] [Abstract][Full Text] [Related]
31. Effects of 12-week administration of dornase alfa in patients with advanced cystic fibrosis lung disease. Pulmozyme Study Group.
McCoy K; Hamilton S; Johnson C
Chest; 1996 Oct; 110(4):889-95. PubMed ID: 8874241
[TBL] [Abstract][Full Text] [Related]
32. Comparison of three jet nebulizer aerosol delivery systems used to administer recombinant human DNase I to patients with cystic fibrosis. The Pulmozyme rhDNase Study Group.
Fiel SB; Fuchs HJ; Johnson C; Gonda I; Clark AR
Chest; 1995 Jul; 108(1):153-6. PubMed ID: 7606951
[TBL] [Abstract][Full Text] [Related]
33. The use of rhDNAse in severely ill, non-intubated adult asthmatics refractory to bronchodilators: a pilot study.
Silverman RA; Foley F; Dalipi R; Kline M; Lesser M
Respir Med; 2012 Aug; 106(8):1096-102. PubMed ID: 22580235
[TBL] [Abstract][Full Text] [Related]
34. Treatment of lobar atelectasis with bronchoscopically administered recombinant human deoxyribonuclease in cystic fibrosis?
McLaughlin AM; McGrath E; Barry R; Egan JJ; Gallagher CG
Clin Respir J; 2008 Apr; 2(2):123-6. PubMed ID: 20298317
[TBL] [Abstract][Full Text] [Related]
35. Clinical studies of rhDNase in moderately and severely affected patients with cystic fibrosis--an overview.
Hodson ME
Respiration; 1995; 62 Suppl 1():29-32. PubMed ID: 7792438
[TBL] [Abstract][Full Text] [Related]
36. New treatment strategies in cystic fibrosis: rhDNase.
Shah PL; Hodson ME
Monaldi Arch Chest Dis; 1996 Apr; 51(2):125-9. PubMed ID: 8680379
[TBL] [Abstract][Full Text] [Related]
37. Short-term recombinant human DNase in bronchiectasis. Effect on clinical state and in vitro sputum transportability.
Wills PJ; Wodehouse T; Corkery K; Mallon K; Wilson R; Cole PJ
Am J Respir Crit Care Med; 1996 Aug; 154(2 Pt 1):413-7. PubMed ID: 8756815
[TBL] [Abstract][Full Text] [Related]
38. Effect of a short course of rhDNase on cough and mucociliary clearance in patients with cystic fibrosis.
Robinson M; Hemming AL; Moriarty C; Eberl S; Bye PT
Pediatr Pulmonol; 2000 Jul; 30(1):16-24. PubMed ID: 10862158
[TBL] [Abstract][Full Text] [Related]
39. DNase in stable cystic fibrosis infants: a pilot study.
Berge MT; Wiel Ev; Tiddens HA; Merkus PJ; Hop WC; de Jongste JC
J Cyst Fibros; 2003 Dec; 2(4):183-8. PubMed ID: 15463871
[TBL] [Abstract][Full Text] [Related]
40. Effect of high-dose ibuprofen in patients with cystic fibrosis.
Konstan MW; Byard PJ; Hoppel CL; Davis PB
N Engl J Med; 1995 Mar; 332(13):848-54. PubMed ID: 7503838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]